Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.55%1.09B | -3.37%713.71M | -9.83%336.23M | -1.38%1.41B | 1.28%1.07B | 2.43%738.59M | 4.38%372.9M | 10.84%1.43B | 13.89%1.06B | 21.74%721.05M |
| Operating revenue | 1.55%1.09B | -3.37%713.71M | -9.83%336.23M | -1.38%1.41B | 1.28%1.07B | 2.43%738.59M | 4.38%372.9M | 10.84%1.43B | 13.89%1.06B | 21.74%721.05M |
| Total operating cost | 4.57%966.63M | 1.59%644.84M | -8.60%294.23M | 3.83%1.26B | 4.19%924.38M | 4.94%634.77M | 4.65%321.93M | 8.88%1.21B | 10.52%887.21M | 18.93%604.89M |
| Operating cost | 5.71%425.69M | 1.15%278.08M | -7.15%123.6M | 7.45%542.15M | 7.89%402.68M | 4.41%274.93M | -2.96%133.12M | 20.89%504.55M | 27.13%373.25M | 43.13%263.33M |
| Operating tax surcharges | -35.10%11.74M | -29.16%8.32M | -6.62%3.11M | 33.72%25.78M | 52.33%18.09M | 74.71%11.75M | 10.34%3.33M | 14.09%19.28M | 18.36%11.88M | 6.52%6.72M |
| Operating expense | 0.13%369.76M | -3.85%241.26M | -12.66%120.76M | -9.04%480.37M | -3.53%369.27M | -0.62%250.92M | 12.04%138.26M | -3.51%528.1M | -7.13%382.78M | -4.79%252.48M |
| Administration expense | 51.14%71.16M | 47.00%48.23M | 37.02%23.25M | -0.53%66.89M | 0.39%47.08M | 10.02%32.81M | 22.44%16.97M | 38.22%67.25M | 41.73%46.9M | 36.63%29.82M |
| Financial expense | 41.59%-7.77M | -169.93%-5.71M | -162.64%-3.08M | -38.97%-17.13M | -312.57%-13.3M | 1.57%-2.12M | -335.72%-1.17M | -62.07%-12.32M | 32.79%-3.22M | 21.69%-2.15M |
| -Interest expense (Financial expense) | ---- | ---- | ---- | --17.21K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Interest Income (Financial expense) | 38.49%-8.41M | -200.88%-5.98M | -178.39%-3.19M | -35.39%-16.84M | -358.41%-13.68M | -11.46%-1.99M | -151.04%-1.15M | -71.79%-12.44M | 28.19%-2.98M | 34.33%-1.78M |
| Research and development | -4.48%96.05M | 12.32%74.66M | -15.36%26.6M | 53.45%158.33M | 32.94%100.56M | 21.54%66.47M | 3.29%31.43M | 16.37%103.18M | 28.86%75.64M | 60.63%54.69M |
| Credit Impairment Loss | -370.46%-912.95K | 67.68%-748.27K | 12.35%-959.93K | 18.22%-1.29M | 104.39%337.55K | -630.78%-2.32M | -680.79%-1.1M | 31.34%-1.58M | 107.79%165.15K | 21.46%-316.81K |
| Asset Impairment Loss | -62.06%-3.91M | 45.93%-1.39M | 99.11%-10.32K | -46.38%-11.11M | 53.32%-2.41M | 14.38%-2.58M | -24.40%-1.16M | -67.55%-7.59M | -198.80%-5.17M | -3,732.55%-3.01M |
| Other net revenue | ||||||||||
| Invest income | 866.29%87.36M | 23.16%-3.18M | 118.80%535.54K | -620.63%-18.66M | -818.25%-11.4M | -246.72%-4.14M | -266.89%-2.85M | -55.06%3.58M | -82.41%1.59M | -59.73%2.82M |
| -Including: Investment income associates | 64.21%-4.08M | -40.21%-5.89M | 53.50%-1.35M | ---18.75M | -189.28%-11.39M | -151.58%-4.2M | -136.21%-2.9M | ---- | -135.96%-3.94M | -105.96%-1.67M |
| Asset deal income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --200.27 | 100.03%200.27 | 100.16%200.27 |
| Other revenue | -53.89%14.8M | -53.41%12.35M | -76.86%4.99M | 81.86%36.28M | 197.81%32.09M | 167.97%26.5M | 639.58%21.55M | 47.68%19.95M | 18.27%10.78M | 76.71%9.89M |
| Operating profit | 32.40%216.52M | -37.43%75.89M | -30.95%46.55M | -31.78%161.77M | -7.02%163.53M | -3.39%121.29M | 25.96%67.42M | 20.97%237.11M | 27.62%175.88M | 31.17%125.55M |
| Add:Non operating Income | 132.55%45.45K | 2,621.56%52.06K | -21.17%1.35K | -62.26%22.04K | -47.16%19.54K | -92.22%1.91K | -86.40%1.71K | -39.81%58.41K | -49.90%36.99K | -65.34%24.59K |
| Less:Non operating expense | 562.50%738.72K | 690.39%722.9K | 90.76%13.99K | -98.47%111.51K | -98.00%111.51K | -98.32%91.46K | -58.67%7.33K | 540.46%7.29M | 1,718.65%5.58M | 2,578.06%5.46M |
| Total profit | 32.05%215.83M | -37.94%75.22M | -30.97%46.54M | -29.67%161.68M | -4.05%163.44M | 0.91%121.2M | 25.96%67.41M | 17.91%229.88M | 23.81%170.34M | 25.67%120.11M |
| Less:Income tax cost | -21.65%18.89M | -39.73%13.1M | -37.14%9.29M | -37.80%22.92M | -6.05%24.11M | 29.10%21.74M | 67.31%14.78M | 70.78%36.84M | 32.35%25.66M | 20.81%16.84M |
| Net profit | 41.34%196.94M | -37.55%62.12M | -29.23%37.25M | -28.12%138.76M | -3.69%139.34M | -3.69%99.46M | 17.79%52.63M | 11.33%193.04M | 22.41%144.68M | 26.50%103.27M |
| Net profit from continuing operation | 41.34%196.94M | -37.55%62.12M | -29.23%37.25M | -28.12%138.76M | -3.69%139.34M | -3.69%99.46M | 17.79%52.63M | 11.33%193.04M | 22.41%144.68M | 26.50%103.27M |
| Less:Minority Profit | 46.62%-10.18M | 32.51%-9M | 46.54%-3.97M | -39.78%-25.56M | -40.33%-19.07M | -49.11%-13.33M | -62.06%-7.42M | -94.19%-18.28M | -128.51%-13.59M | -309.92%-8.94M |
| Net profit of parent company owners | 30.75%207.12M | -36.95%71.12M | -31.37%41.21M | -22.24%164.32M | 0.09%158.41M | 0.52%112.79M | 21.90%60.05M | 15.60%211.32M | 27.49%158.27M | 33.87%112.21M |
| Earning per share | ||||||||||
| Basic earning per share | 30.58%1.58 | -37.21%0.54 | -31.25%0.44 | -22.22%1.75 | -28.40%1.21 | -28.33%0.86 | 20.75%0.64 | 15.38%2.25 | 28.03%1.69 | 34.83%1.2 |
| Diluted earning per share | 30.58%1.58 | -37.21%0.54 | -31.25%0.44 | -22.22%1.75 | -28.40%1.21 | -28.33%0.86 | 20.75%0.64 | 15.38%2.25 | 28.03%1.69 | 34.83%1.2 |
| Other composite income | ||||||||||
| Total composite income | 41.34%196.94M | -37.55%62.12M | -29.23%37.25M | -28.12%138.76M | -3.69%139.34M | -3.69%99.46M | 17.79%52.63M | 11.33%193.04M | 22.41%144.68M | 26.50%103.27M |
| Total composite income of parent company owners | 30.75%207.12M | -36.95%71.12M | -31.37%41.21M | -22.24%164.32M | 0.09%158.41M | 0.52%112.79M | 21.90%60.05M | 15.60%211.32M | 27.49%158.27M | 33.87%112.21M |
| Total composite income of minority owners | 46.62%-10.18M | 32.51%-9M | 46.54%-3.97M | -39.78%-25.56M | -40.33%-19.07M | -49.11%-13.33M | -62.06%-7.42M | -94.19%-18.28M | -128.51%-13.59M | -309.92%-8.94M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.